Endocyte taking cancer detection drug into clinical trials WEST LAFAYETTE, IN (wbaa) - Detecting prostate cancer could be easier with a new method developed at a Purdue Research Park company.

Professor Philip Low is leading the effort, which soon will be in clinical trials.

His company, Endocyte, has developed a drug that homes in exclusively on infected cells.

The method should allow a more targeted treatment of the cancer and prevent many of the usual chemotherapy side effects, such as hair loss.

The program may lead to treatments of other cancers as well.
© Copyright 2012, wbaa